Literature DB >> 33099778

Basophil activation and serum IL-5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti-IL-5 drugs.

Cristiano Caruso1, Stefania Colantuono1,2, Barbara Tolusso3, Clara Di Mario4, Antonella Pentassuglia5, Gabriele Rumi1, Elisa Gremese3,4, Antonino Romano6,7, Antonio Gasbarrini8.   

Abstract

Entities:  

Keywords:  asthma; basophil; eosinophils; interleukins

Mesh：

Substances：

Year:  2020        PMID： 33099778     DOI： 10.1111/all.14643

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  3 in total

1.  Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis.

Authors:  Cristiano Caruso; Paolo Cameli; Elena Altieri; Maria Aliani; Pietro Bracciale; Luisa Brussino; Maria Filomena Caiaffa; Giorgio Walter Canonica; Stefano Centanni; Maria D'Amato; Stefano Del Giacco; Fausto De Michele; Elide Anna Pastorello; Girolamo Pelaia; Paola Rogliani; Micaela Romagnoli; Pietro Schino; Marco Caminati; Alessandra Vultaggio; Alessandro Zullo; Sara Rizzoli; Silvia Boarino; Gianfranco Vitiello; Francesco Menzella; Fabiano Di Marco
Journal:  Front Med (Lausanne)       Date:  2022-09-02

2.  Heterogeneous Response of Airway Eosinophilia to Anti-IL-5 Biologics in Severe Asthma Patients.

Authors:  Maruša Kopač Šokić; Matija Rijavec; Peter Korošec; Urška Bidovec-Stojkovič; Izidor Kern; Romana Vantur; Sabina Škrgat
Journal:  J Pers Med       Date:  2022-01-07

Review 3.  Heterogeneous Condition of Asthmatic Children Patients: A Narrative Review.

Authors:  Cristiano Caruso; Stefania Colantuono; Stefania Arasi; Alberto Nicoletti; Antonio Gasbarrini; Angelo Coppola; Loreta Di Michele
Journal:  Children (Basel)       Date:  2022-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.